Poster Abstract Session:
134. Antibiotic Stewardship: General Acute Care Implementation and Outcomes
Friday, October 28, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Epidemiology and Infection Control, Adult ID

Presentations:
961
Adherence to International Empiric Antibiotic Treatment Guidelines in a Tertiary Teaching Hospital in Mexico City
Marco Antonio Rodríguez-Cervera, MD. Student ; Paulo Francisco Castañeda-Mendez, MD. ; Luis Soto-Ramírez, MD ; Lorena Cabrera-Ruiz, MD
962
Variation in Use Metrics by Type of Antibiotic and Among Veterans Affairs Acute Care Medical Facilities
Michael Rubin, MD, PhD, FIDSA ; Molly Leecaster, PhD ; Vanessa W. Stevens, PhD ; Damon Toth, PhD ; Karim Khader, PhD ; Jian Ying, PhD
Posters
  • Poster962.png (1.6 MB)
  • 963
    NHSN SAAR Assessment Using Visual Analytics: Tools to Improve Population Antimicrobial Use
    Jefferson Bohan, PharmD ; Matthew Bidwell Goetz, MD ; Christopher J. Graber, MD, MPH, FIDSA ; Makoto Jones, MD, MS ; Sarah Mcclain, PharmD, BCPS ; Emily Spivak, MD ; Maximillian Jahng, PharmD ; Matthew Samore, MD, FSHEA ; Peter Glassman, MBBS, MSc ; Karl Madaras-Kelly, PharmD., MPH
    964
    The ‘morning dip’ in antimicrobial appropriateness
    Jonne Sikkens, MD MSc ; Sophie Gerritse, MD MSc ; Edgar Peters, MD, PhD ; Mark Kramer, MD PhD ; Michiel Van Agtmael, MD PhD
    965
    Clinical Nurses are Active Partners in Antimicrobial Stewardship Efforts: Results from a Multisite Survey
    William Greendyke, MD ; Eileen J. Carter, PhD, RN ; Elizabeth Salsgiver, MPH ; Daniel Bernstein, BA ; Matthew S. Simon, MD, MS ; Lisa Saiman, MD, MPH, FSHEA ; E. Yoko Furuya, MD, MS ; David P. Calfee, MD, MS, FIDSA, FSHEA
    966
    Development of Operationalized Intravenous to Oral Antibiotic Switch Therapy Criteria
    Hassna Akhloufi, PhD candidate ; Marlies Hulscher, Professor ; Heleen Van Der Sijs, PhD ; Jan M. Prins, Professor, MD ; Damian Melles, MD ; Annelies Verbon, Professor, MD
    Posters
  • 1Poster%20ID%20Week%202-3.pdf (757.7 kB)
  • 967
    The First Step is Always the Hardest: Building a Framework for Stewardship across a Large, Diverse Healthcare System
    Julie E. Williamson, PharmD ; Andrea Y. Logan, PharmD ; Emily K. Reinke, PhD ; Steven Jarrett, PharmD ; Cynthia Clarke, RPh ; Lisa E. Davidson, MD
    968
    How Ready Are Hospitals to Meet The Centers for Medicare & Medicaid Antibiotic Stewardship Requirements?
    Shaina Bernard, PharmD, BCPS ; Amy Pakyz, PharmD, MS, PhD ; Kristi Kuper, PharmD, BCPS ; Natalie Nguyen, PharmD, MSHA ; Michael Stevens, MD, MPH
    969
    What Antimicrobial Stewardship Interventions Are We Focusing on? The Experience of a Large Healthcare System
    Florian Daragjati, PharmD, BCPS ; Roy Guharoy, PharmD, MBA ; Clariecia Groves, M.S. ; Danielle Sebastian, PharmD ; Mohamad Fakih, MD, MPH, FIDSA
    970
    The Microbiology Laboratory is a Valuable, but Largely Underutilized Partner in Antimicrobial Stewardship and Antimicrobial Resistance Monitoring
    James a. Mckinnell, MD ; Erin Epson, MD ; Sam Horwich-Scholefield, MPH, CIC ; Romney Humphries, PhD ; Janet Hindler, MCLS, MT(ASCP) ; Loren Miller, MD, MPH ; Job Mendez, RN, MD ; Dawn Terashita, MD, MPH ; Patricia Marquez, MPH, CIC ; Sandeep Bhaurla, MPH ; Christina Hershey, BA ; Jeremias Martinez, BS ; Marcelo Moran, MA, MPH ; Lindsey Pandes, MPH ; Lauri Thrupp, MD, FIDSA, FSHEA
    971
    Anti-MRSA Agents Use in the Era of Active antimicrobial Stewardship Programs: Is there a Difference Based on Hospital Size?
    Roy Guharoy, PharmD, MBA ; Jeffrey Seggerman, MBA ; Clariciea Groves, MS ; Florian Daragjati, PharmD, BCPS ; Dan Leffler, MS ; Danielle Sebastian, PharmD ; Mohamad Fakih, MD, MPH, FIDSA
    972
    A Dynamic 2-in-1 Approach to Infection Control and Antibiotic Stewardship in a Long Term acute Care Hospital
    Sindhura Kompella, M.D. ; Suganya Chandramohan, M.D. ; Amar Krishna, MD ; John Kacir, R.N ; Teena Chopra, M.D. M.P.H
    973
    Outcomes Associated with Antimicrobial De-escalation of Treatment for Healthcare-associated Pneumonia (HCAP) within the Veterans Healthcare Administration
    Jefferson Bohan, PharmD ; Richard Remington, MS ; Makoto Jones, MD, MS ; Matthew Samore, MD, FSHEA ; Karl Madaras-Kelly, PharmD., MPH
    974
    Implementing a Cost-Effective Antibiotic Stewardship Program at Two Non-Teaching Community Hospitals
    Jennifer Bui, Pharm. D ; Faheem Younus, MD, FIDSA ; Mehboob Rehan, MD
    975
    Internally-Developed Antimicrobial Use Benchmarking at a Large Academic Medical Center and Integrated Health System
    Vasilios Athans, PharmD ; Elizabeth Neuner, PharmD ; Andrea Pallotta, PharmD ; Jeffrey Chalmers, PharmD ; Eric Vogan, BSPS, MS ; Xin Jiang, MS ; Thomas G. Fraser, MD, FSHEA ; Steven Gordon, MD, FIDSA, FSHEA
    977
    The Impact of Incorporating Infectious Diseases Led Antimicrobial Stewardship into Multidisciplinary Rounds in the Intensive Care Unit
    Angelina Davis, PharmD, MS ; Christine Zurawski, MD ; Jesse Couk, MD ; Todd Parker, PharmD ; Daniel Sexton, MD ; Rebekah W. Moehring, MD, MPH
    Posters
  • PHC-DASON FINAL Poster.pdf (351.1 kB)
  • 978
    Leveraging Online Curricula for Antimicrobial Stewardship: Training Providers to Optimize Therapy with Antibiotic Timeouts
    Marisa Holubar, MD, MS ; Kimberly Walker, PhD ; Huy Tran, BA ; Lina Meng, PharmD ; Emily Mui, PharmD ; Elizabeth Robilotti, MD MPH ; Stan Deresinski, MD, FIDSA
    Posters
  • ATOCME_IDWEEK2016.pdf (3.1 MB)
  • 979
    Implementation of an Antibiotic Stewardship Program to Increase Appropriate Antibiotic Use in the Hospital on Aruba 
    Frederike V. Van Daalen, MD ; Anouk Lagerburg, BSc ; Jaclyn De Kort, MD ; Elena Sánchez-Rivas, MD ; Jan M. Prins, Professor, MD ; Brent C. Opmeer, PhD ; Marlies E.J.L. Hulscher, Professor ; Suzanne E. Geerlings, Professor, MD
    980
    Use of Constant reminders through electronic health record after an initial educational session to decrease inappropriate antibiotic prescriptions for asymptomatic bacteriuria.
    Ahmed Abubaker, MD ; Dawd Siraj, MD ; Paul Cook, MD, FIDSA ; Muhammad Salman Ashraf, MD ; Michael Gooch, MS, RPh ; Michelle Jordan, Pharm D ; Salma Mohamed, MD ; Jonathan Polak, MD ; Dora Lebron, MD ; Nada Fadul, MD
    981
    Patients with Advanced Stage Pressure Ulcers: Identifying an Opportunity for Targeted Antimicrobial Stewardship
    Marné Garretson, MPH ; Anna Flattau, MD, MSc, MS ; Maryrose Defino, RN, MS, CPHQ ; Arinola Makinde, RN ; Elizabeth Gancher, MD ; Cary Andrews, PA, MS, CWS ; Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA
    Posters
  • MGPosterDraft5.pdf (371.8 kB)
  • 984
    Medication Errors Associated with the Use of Beta-Lactam Antibiotics in Russian Federation
    Sergey Zyryanov, MD, Prof, PhD ; Irina Asetskaya, MD, PhD ; Anna Kuzmina, MD ; Vitaliy Polivanov, MD
    Posters
  • VIT_11.pdf (341.8 kB)
  • 985
    The Students for Antimicrobial Stewardship Society: A Novel, Grassroots Educational Approach to Growing a Culture of Antimicrobial Stewardship
    Sarah Silverberg, B.Arts.Sc ; Alainna Jamal, BSc ; Vanessa Zannella, MSc ; Ali Damji, BSc ; J. Antonio Lee, MPH ; Andrew Morris, MD, SM
    Posters
  • IDWeek Poster Draft.pdf (1.6 MB)
  • 986
    Unnecessary Antibiotic Use Among Patients with Blood Cultures Positive for Viridans Streptococci
    Sonal Bajaj, MD ; David C. Perlman, MD ; Polina Lerner, PharmD ; Marianna Fedorenko, PharmD ; Donna Mildvan, M.D. ; Jorg Ruhe, MD
    987
    Core Elements of Hospital Antibiotic Stewardship Programs: An Evaluation in Seven Colombian Hospitals
    Marta Vallejo, MD, Surgeon, MSc. ; Diana Cuesta, MD, MSc, PhD. ; Wilder Castaño, MD. Intensive care MD ; Luz Bustacara, NP ; Ines Loaiza, MD. ; Norton Perez, MD. Intensive care MD
    988
    Multicenter Study to evaluate the impact of Antibiotic Time Out in Four Community Hospitals
    Radhika S. Polisetty, PharmD, BCPS, AQ-ID ; Jaime Borkowski, PharmD, BCPS ; Elizabeth Jochum, PharmD, BCPS ; Jennifer Delacruz, MD, MS ; Steven Lewis, MD ; Bob Manam, MD ; David Cooke, MD ; Luis Manrique, MD
    Posters
  • IDWeekposter2016RP.pdf (613.9 kB)
  • 989
    Intervention to Improve Performance of Antimicrobial Automatic Stop Orders
    Alyssa Yeager, BA ; Yevgeniy Gitelman, MD ; Steven Morgan, PharmD, BCPS, AQID ; Jillian Dougherty, PharmD ; Daniel Timko, PharmD, BCPS, AQID ; Shawn Binkley, BS, PharmD ; Keith Hamilton, MD
    Posters
  • Poster_IDweek.pdf (229.9 kB)
  • 990
    Effectiveness of carbapenems and piperacillin/tazobactam antimicrobial stewardship at a Japanese tertiary care center: the impact on changes in the use of other antipseudomonal agents
    Hitoshi Honda, MD, PhD ; Mikihiro Horiuchi, BSc ; Masanori Higuchi, MD ; Shutaro Murakami, BSc ; Yasuaki Tagashira, MD ; Yasuharu Tokuda, MD MPH
    991
    Point Prevalence Survey of Antimicrobial Prescriptions at a Tertiary Hospital in Southern Ireland, 2015
    Zakariya Al Balushi, MD ; Mala Shah, BPharm, MSc Clinical Pharmacy Practice ; Diana Hogan-Murphy, BA, H.Dip (Computer Science), Masters in IT, B.Sc in Pharmacy, M.Sc in Clinical Pharmacy ; Arthur Jackson, MD
    992
    Does voluntary e-learning on antibiotics improve medical students’ prescribing skills later on?
    Jonne Sikkens, MD MSc ; Martine Caris, MD MSc ; Jelle Tichelaar, MSc ; Tim Schutte, MD MSc ; Mark Kramer, MD PhD ; Michiel Van Agtmael, MD PhD
    993
    Antibiotic consumption from 2013to 2015 at Colombian hospitals of third level of complexity.
    Carlos Alvarez, MD; FIDSA ; Carlos Gomez, MD ; Anita Montañez, BSc ; Diego Ballen, MD ; Sandra Liliana Valderrama Beltran, MD ; Sandra Gualteros, MD ; Karen Ordoñez, MD ; Diego Bonilla, MD ; Otto Sussmann, MD
    994
    Use of the Epic Antimicrobial Stewardship Module Optimizes Efficiency and Increases Case Finding for Stewardship Interventions
    Emily Mui, PharmD ; Lina Meng, PharmD ; Vinhkhoa Nguyen, PharmD ; Gabriela Espinosa, MS ; Marisa Holubar, MD, MS ; Stan Deresinski, MD, FIDSA
    Posters
  • IDWeek E.Mui.pdf (517.2 kB)
  • 997
    Compliance with Institutional Skin and Soft Tissue Infection Guidelines and Associated Outcomes
    Jared Borlagdan, Pharmacy student ; Carol Chenoweth, MD, MS, FSHEA, FIDSA ; Tejal Gandhi, MD ; Jerod Nagel, PharmD
    998
    Defined Daily Doses of Antibiotic Consumption and Clostridium difficile Infection Rates in a University Hospital
    Laura Paláu-Dávila, M.D. ; Elvira Garza-Gonzalez, PhD ; Edelmiro Pérez-Rodríguez Sr., M.D., Ph.D. ; Adrian Camacho-Ortiz, M.D., PhD
    Posters
  • DDDandCDIO.pdf (1.3 MB)
  • 999
    Impact of a Newly Implemented Antimicrobial Stewardship Program for Patients with Bloodstream Infections (BSI) in the Absence of Rapid Diagnostic Technology (RDT)
    Enrique Cornejo Cisneros, MD ; Philippe Morency-Potvin, MD ; Sheila Wang, PharmD, BCPS AQ-ID ; Andrew Simms, MD ; David C. Nguyen, MD ; Christy a. Varughese, PharmD ; Amy Hanson, PharmD ; Kamaljit Singh, MD ; Gordon M. Trenholme, MD ; Sarah Won, M.D.
    Characteristics of primary medical team disagreements with antimicrobial stewardship program interventions
    Joshua Herigon, MD, MPH ; Brian Lee, MPH, PhD ; Karisma Patel, PharmD ; Jason Newland, MD, MEd, FPIDS ; Jennifer Goldman, MD, MS
    Impact of the Verigene Rapid Diagnostic Blood Test as an Antibiotic Stewardship Tool amongst Hospitalized Patients in a Community Healthcare System
    Christopher Fronczek, Pharm.D. ; Nicholas Piccicacco, Pharm.D. ; William Braun, Pharm.D. ; Joanna Caranante, Pharm.D. ; Jennifer Moeller, Pharm.D. ; Lynne Krop, Pharm. D. ; Jonathan Grey, Pharm.D.
    Evaluation of a Microbiologist-initiated Service to Improve Antibiotic Prescribing for Bacteremia
    Yee Ding Ng, MPharm with Hons. ; Pu En Ow Yong, MPharm with Hons. ; Teck Kim Tie, MID ; Jonathan Seah, PharmD ; Michelle See, PharmD ; Raymond Kok Choon Fong, MBBS, MRCP, DTMH ; Humaira Shafi, MBBS, ABIM ; Thean Yen Tan, MBBCh, MRCPath ; Qiu Min Yeo, PharmD
    Using the Standardized Antimicrobial Administration Ratios to monitor the influence of antimicrobial stewardship activities
    Daniel Livorsi, MD, MSc ; Erin O'leary, MPH ; Tamra Pierce, PharmD ; Lindsey Reese, MD ; Katharina Van Santen, MSPH ; Daniel Pollock, MD ; Jonathan R. Edwards, MStat ; Arjun Srinivasan, MD, FSHEA
    Posters
  • Livorsi ID week abstract.pdf (565.4 kB)
  • Impact of Requiring Reapproval on Day Three of Restricted Antibiotic Therapy
    Khalid Eljaaly, PharmD, CAPPS, BCPS ; Salwa Elarabi, RPh, BCPS ; Samah Alshehri, PharmD, CAPPS, BCPS ; David Nix, PharmD
    Posters
  • ASP_Reapproval.pdf (287.2 kB)
  • Streamlining Daptomycin Therapy in an Academic Medical Center
    Betty N. Vu, PharmD ; Philip Chung, PharmD, MS ; Julie E. Williamson, PharmD ; Yi Guo, PharmD
    Associations Between Antimicrobial Stewardship Program Elements and Clostridium difficile Infection Performance
    Amy Pakyz, PharmD, MS, PhD ; Giulia Barlow, BS ; Julie Patterson, BS ; Jeremy Stultz, PharmD
    A Matched Cohort Study Evaluating the Comparative Incidence of Adverse Renal Outcomes in Patients Receiving Vancomycin and Piperacillin-Tazobactam in Combination or as Monotherapy
    Joseph Carreno, PharmD ; Tori Smiraglia, BS Candidate ; Christopher Hunter, BS ; Ellis Tobin, MD, FIDSA ; Ben Lomaestro, PharmD
    Impact of an Innovative Smartphone “App” on Intensive Care Unit (ICU) Antimicrobial Utilization Across a Large Metropolitan Health Region in Canada: an Interrupted Time Series Analysis
    Stephen Robinson, MD ; Paul Campsall, MD ; Elizabeth Parfitt, MD ; John Conly, MD ; Bruce Dalton, BScPharm, PharmD ; William Stokes, MD ; Barry Kushner, BScPharm ; Stephen Vaughan, MD ; Bayan Missaghi, MD ; Vikas Chaubey, MD ; Daniel Gregson, MD ; Dan Zuege, MD
    Impact of an Antimicrobial Stewardship Protocol on Appropriateness of Meropenem Use in a Community Hospital
    Cristina Reyes, PharmD ; Melissa Johnson, PharmD, MHS ; Emma Castillo, MD ; Michael Lamonds, PharmD ; Rebekah W. Moehring, MD, MPH ; Luke Heuts, PharmD, BCPS
    Denominator Matters in estimating Antimicrobial Use: A comparison of days present and patient days
    Rebekah W. Moehring, MD, MPH ; Yuliya Lokhnygina, MS, PhD ; Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS ; Arthur W. Baker, MD, MPH ; Sarah S. Lewis, MD MPH ; Daniel Sexton, MD ; Deverick Anderson, MD, MPH, FIDSA, FSHEA
    Antimicrobial Stewardship Initiative to Reduce Antibiotic Use for Asymptomatic Bacteriuria (ASB)
    Ameen Pirasteh, PharmD ; Sheila Wang, PharmD, BCPS AQ-ID ; Amy Hanson, PharmD ; Gary Peksa, PharmD, BCPS ; Sarah Won, M.D. ; John Segreti, MD, FIDSA, FSHEA ; Holly Harrison, PharmD Candidate ; Jane Lee, PharmD Candidate
    Posters
  • ASB_IDWeek_10 2016FINAL.pdf (902.8 kB)
  • Evaluation of the impact of an antimicrobial stewardship program initiative in patients with uncomplicated acute bacterial skin and skin structure infections
    Monika Murillo, MD ; Tamara Trienski, PharmD ; Derek Bremmer, PharmD ; Noreen Chan-Tompkins, PharmD, BCPS-AQ ID ; Lynn Chan, PharmD ; Chelsea Konopka, PharmD ; Michael Burkitt, MD, MPH ; Matthew Moffa, DO ; Courtney Watson, MPH ; Thomas Walsh, MD, PhD (hon), FIDSA, FAAM
    Out of Sight – Out of Mind: Impact of Cascade Reporting on Escherichia spp and Klebsiella Infections
    Siyun Liao, Pharm.D., PhD, BCPS ; Judith Rhodes, Ph.D., DABMM ; Madhuri Sopirala, MD, MPH
    Universal Implementation of Antimicrobial Stewardship Programs Leads to Reduction in Antibiotic Use and Cost Savings: Pilot Results from a Large U.S. Health System 
    Roy Guharoy, PharmD, MBA ; Mohamad Fakih, MD, MPH, FIDSA ; Jeffrey Seggerman, MBA ; Florian Daragjati, PharmD, BCPS ; Clariciea Groves, MS ; Karen Smethers, Pharm.D. ; Danielle Sebastian, PharmD ; Dan Leffler, MS ; Ann Hendrich, RN, PhD
    Clinical and Economic Impact of the Implementation of an Antibiotic Flowchart for Complicated Urinary Tract Infection in a Tertiary Care Hospital in Colombia
    Sergio Reyes, MD ; Christian Pallares, MD, MSc ; Cristhian Hernández-Gómez, BSc ; Kevin Escandón-Vargas, MD ; David Aragon, MD ; Maria Virginia Villegas, MD, MSc, FIDSA
    Posters
  • Poster Flujogramas final.pdf (491.7 kB)
  • Economic Impact of an Antimicrobial Stewardship Program Implementation in Three High-Complexity Hospitals in Colombia
    Cristhian Hernández-Gómez, BSc ; Christian Pallares, MD, MSc ; Kevin Escandón-Vargas, MD ; Sergio Reyes, MD ; Soraya Salcedo, MD, MSc ; Lorena Matta, MD, MSc ; Maria Virginia Villegas, MD, MSc, FIDSA
    Posters
  • Poster AMS final.pdf (462.9 kB)
  • Evaluation of Management of Community Acquired Pneumonia Prior to Implementation of an Antimicrobial Stewardship Program Initiative: A Retrospective Assessment
    Thomas Walsh, MD, PhD (hon), FIDSA, FAAM ; Briana Disilvio, MD ; Daniel Speredelozzi, MD ; Crystal Hammer, MD ; Kurt Hu, MD ; Rasha Abdulmassih, MD ; Jina Makadia, MD ; Rikinder Sandhu, MD ; Mouhib Naddour, MD ; Swati Vishwanathan, MD ; Noreen Chan-Tompkins, PharmD, BCPS-AQ ID ; Tamara Trienski, PharmD ; Matthew Moffa, DO ; Derek Bremmer, PharmD
    Posters
  • Cap Poster App Upload.pdf (369.5 kB)
  • Antibiotic Stewardship Program Impact on Clostridium difficile Incidence in a 232 Bed Community Hospital
    Michael Hill, MD ; Jo Watkins, RPh ; Ashley Wilson, PharmD ; Julie Nevers, RN, MN ; Leslie Kelt, CIC, CPHQ ; Wendy Talley, RPh
    Posters
  • IDSA Poster Final.pdf (1.3 MB)
  • Re-evaluation of Antimicrobial Resistance Patterns 7 Years after Change in Institutional Guidelines for Uncomplicated Cystitis.
    Patrick Ryan, MD ; Connie Price, MD ; Bryan Knepper, MPH, MSc, CIC ; Rachel Everhart, PhD
    Influence of Beta-lactam Infusion Strategy on Acute Kidney Injury
    Sarah Cotner, PharmD ; W. Cliff Rutter, PharmD ; Donna R. Burgess, RPh ; Craig Martin, PharmD, MBA ; David S. Burgess, PharmD, FCCP
    Posters
  • Cotner ID Week Poster.pdf (509.5 kB)
  • Ongoing Impact of an Antimicrobial Stewardship Program at A Large Academic Medical Center, 9 years of experience
    Susan Kline, MD, MPH, FSHEA ; Kimberly Boeser, PharmD, BCPS AQ-ID ; Pamela Phelps, Pharm D ; Dawn England, MPH, CIC ; Samantha Saunders, MPH ; Kari Lawrence, MPH, BBA ; Jessica Kanklefitz, BA
    Impact of a Multi-Faceted Stewardship Intervention on Duration of Antibiotic Therapy for the Treatment of Community-Acquired Pneumonia (CAP)
    Farnaz Foolad, PharmD ; Angela Huang, PharmD, BCPS-AQ ID ; Cynthia Nguyen, PharmD ; Megan Mack, MD ; Tejal Gandhi, MD ; Gregory Eschenauer, PharmD ; Twisha Patel, PharmD ; Vince Marshall, BS, MS ; Lindsay Colyer, P4 Student ; Megan Lim, P4 Student ; Jerod Nagel, PharmD
    A Comparison of Staphylococcus aureus Bacteremia (SAB) Diagnosis and Management: Differences Between Academic and Community Hospital Settings
    Sumaya Ased, PharmD ; Renuga Vivekanandan, MD ; Jennifer Anthone, PharmD ; Hamza Rayes, MD ; Jaspreet Dhami, MD ; Ann Cabri, PharmD Candidate ; Michele Davids, PharmD ; Thomas Amosson, MD ; Jeff Macaraeg, MD ; Akua Fordjour, MD ; Josh Wilson, MD Candidate ; Christopher Destache, PharmD
    Posters
  • 2016 IDSA SAB.pdf (905.7 kB)
  • Effectiveness of Prudent Use of Vancomycin after a Vancomycin Resistant Enterococci (VRE) Outbreak in a Non-endemic, Tertiary Care Hospital
    Pasri Maharom, MD, MPH ; Sorapop Pakdeewongse, M.D. ; Aungsumalin Sricharoon, BNS ; Kaimuk Thongyen, BNS ; Kasama Canchanapan, M.S. (Clinical Pharmacy) ; Saisamorn Charoenngampit, M.S. (Clinical Pharmacy) ; Chirapan Tantimongkolsuk, MD
    Posters
  • IDWeek 2016_poster.pdf (430.6 kB)
  • Antimicrobial stewardship interventions for Staphylococcus aureus bacteremia: cost analysis of alternative therapies
    Chas Hoffmann, PharmD ; Christopher Evans, MD, MPH ; David Hutchinson, PharmD ; Jack Brown, PharmD, MS, BCPS, FCCP
    Factors Associated with De-escalation in Patients with Healthcare-Associated Pneumonia
    Lorrance Majewski, DO ; Nobuhiro Ariyoshi, MD ; Zao Zhang, MD ; Nattawat Klomjit, MD ; Heath Chung, MD
    Successful antimicrobial stewardship interventions in a Dutch general hospital
    Gerard Van Asselt, MD, PhD ; Casper Van Der Hoeven, PharmD ; Suba Lugtenburg, MD ; Chris Roggeveen, MD
    Posters
  • Poster IDweek 20160808 pdf.pdf (804.8 kB)
  • Impact of Mandatory Infectious Diseases Consultation on Fungemia Management at a Large Academic Medical Center
    Travis Jones, PharmD ; Dustin Wilson, PharmD ; Christina Sarubbi, PharmD ; Deverick Anderson, MD, MPH, FIDSA, FSHEA ; Richard H. Drew, PharmD, MS, BCPS, FCCP
    Posters
  • Poster 1036 IDWeek 2016.pdf (288.3 kB)
  • Comparison of Metronidazole q12h to q8h in Combination with Other Antibiotics on the Clinical Outcome and Readmission Rate of Patients with Appendicitis and Diverticulitis.
    Lizanne Béïque, BPharm, PharmD ; Corey Tsang, BScPhm ; Stephanie Geertsema, BScPhm ; Rosemary Zvonar, BScPhm, ACPR, FCSHP ; Caroline Nott, MBBS, FRCPC ; Janet Squires, RN, PhD ; Kathryn Suh, MD, MSc, FRCPC
    Evaluating Antibiotic Use and Recurrent CDI Risk Among Hospitalized Patients with a History of Clostridium Difficile Infection: Opportunities in Stewardship
    Jeffrey Wang, MD ; Kathleen a. Quan, RN, MSN, CIC ; Thomas Tjoa, MPH, MS ; Jennifer Yim, RN, BSN, CIC ; Linda Dickey, RN, MPH, CIC ; Justin Chang, BS ; Susan S. Huang, MD, MPH, FIDSA, FSHEA ; Shruti K. Gohil, MD, MPH

    CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.